Royalty Pharma PLCNASDAQ:RPRX
- LAST PRICE28.1200
- TODAY'S CHANGE (%)0.1200 (0.4286%)
- Bid / Lots27.5500/ 1
- Ask / Lots28.9200/ 7
- Open / Previous Close28.0400 / 28.0000
- Day Range
- 52 Week Range
- Volume3,605,078
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RPRX |
|---|---|---|
| 09:32 ET | 36612 | 27.975 |
| 09:34 ET | 2300 | 28.06 |
| 09:36 ET | 4212 | 28.05 |
| 09:38 ET | 3215 | 28.14 |
| 09:39 ET | 5682 | 28.11 |
| 09:41 ET | 3987 | 28.1 |
| 09:43 ET | 12124 | 28.1 |
| 09:45 ET | 2238 | 28.13 |
| 09:48 ET | 2025 | 28.1 |
| 09:50 ET | 8568 | 28.095 |
| 09:52 ET | 6881 | 28.125 |
| 09:54 ET | 4517 | 28.09 |
| 09:56 ET | 5680 | 28.06 |
| 09:57 ET | 4364 | 28.01 |
| 09:59 ET | 7502 | 28 |
| 10:01 ET | 114131 | 28.005 |
| 10:03 ET | 31446 | 28.0675 |
| 10:06 ET | 19336 | 28.065 |
| 10:08 ET | 4618 | 28.02 |
| 10:10 ET | 2912 | 28.005 |
| 10:12 ET | 4835 | 28.035 |
| 10:14 ET | 4802 | 28.025 |
| 10:15 ET | 3674 | 28.025 |
| 10:17 ET | 11096 | 28.035 |
| 10:19 ET | 16494 | 27.995 |
| 10:21 ET | 32176 | 28.03 |
| 10:24 ET | 14752 | 28.01 |
| 10:26 ET | 8378 | 28.025 |
| 10:28 ET | 19248 | 28.035 |
| 10:30 ET | 12576 | 28.025 |
| 10:32 ET | 18577 | 28.02 |
| 10:33 ET | 51209 | 28.015 |
| 10:35 ET | 20475 | 28.04 |
| 10:37 ET | 20829 | 28.035 |
| 10:39 ET | 7977 | 28.14 |
| 10:42 ET | 7442 | 28.065 |
| 10:44 ET | 11653 | 28.0314 |
| 10:46 ET | 2024 | 28.025 |
| 10:48 ET | 7404 | 28.01 |
| 10:50 ET | 5243 | 28.01 |
| 10:51 ET | 3676 | 27.995 |
| 10:53 ET | 120893 | 28.03 |
| 10:55 ET | 5959 | 28.035 |
| 10:57 ET | 39574 | 28.01 |
| 11:00 ET | 1419 | 28.01 |
| 11:02 ET | 3168 | 28.015 |
| 11:04 ET | 22632 | 28.01 |
| 11:06 ET | 9368 | 28.015 |
| 11:08 ET | 5363 | 28.01 |
| 11:09 ET | 6731 | 28.055 |
| 11:11 ET | 13772 | 28.035 |
| 11:13 ET | 24163 | 28.0422 |
| 11:15 ET | 29896 | 28.05 |
| 11:18 ET | 23660 | 28.06 |
| 11:20 ET | 9225 | 28.07 |
| 11:22 ET | 5358 | 28.07 |
| 11:24 ET | 1480 | 28.075 |
| 11:26 ET | 6705 | 28.055 |
| 11:27 ET | 13469 | 28.055 |
| 11:29 ET | 2857 | 28.07 |
| 11:31 ET | 6563 | 28.035 |
| 11:33 ET | 2236 | 28.04 |
| 11:36 ET | 2801 | 28.0275 |
| 11:38 ET | 2747 | 28.025 |
| 11:40 ET | 9863 | 28 |
| 11:42 ET | 3635 | 27.98 |
| 11:44 ET | 1800 | 27.985 |
| 11:45 ET | 723 | 27.995 |
| 11:47 ET | 4616 | 27.9791 |
| 11:49 ET | 2600 | 28.005 |
| 11:51 ET | 1200 | 27.975 |
| 11:54 ET | 2238 | 27.985 |
| 11:56 ET | 1933 | 28 |
| 11:58 ET | 4215 | 28.01 |
| 12:00 ET | 1700 | 28.015 |
| 12:02 ET | 4317 | 28.02 |
| 12:03 ET | 2434 | 28.05 |
| 12:05 ET | 5638 | 28.04 |
| 12:07 ET | 1638 | 28.025 |
| 12:09 ET | 3273 | 28.03 |
| 12:12 ET | 3600 | 28.04 |
| 12:14 ET | 1984 | 28.02 |
| 12:16 ET | 400 | 28.025 |
| 12:18 ET | 62226 | 28.05 |
| 12:20 ET | 100 | 28.055 |
| 12:21 ET | 3625 | 28.045 |
| 12:23 ET | 8488 | 28.025 |
| 12:25 ET | 10872 | 28.02 |
| 12:27 ET | 7508 | 28 |
| 12:30 ET | 5004 | 28 |
| 12:32 ET | 7429 | 28 |
| 12:34 ET | 2700 | 28 |
| 12:36 ET | 1291 | 28.01 |
| 12:38 ET | 2636 | 28.015 |
| 12:39 ET | 3754 | 28.015 |
| 12:41 ET | 2900 | 28.02 |
| 12:43 ET | 1118 | 28.02 |
| 12:45 ET | 4699 | 28.01 |
| 12:48 ET | 400 | 28.015 |
| 12:50 ET | 20778 | 28.025 |
| 12:52 ET | 2883 | 28.02 |
| 12:54 ET | 750 | 28.015 |
| 12:56 ET | 7495 | 28.06 |
| 12:57 ET | 6895 | 28.055 |
| 12:59 ET | 4666 | 28.06 |
| 01:01 ET | 14053 | 28.07 |
| 01:03 ET | 900 | 28.075 |
| 01:06 ET | 800 | 28.08 |
| 01:08 ET | 4324 | 28.1253 |
| 01:10 ET | 4205 | 28.14 |
| 01:12 ET | 6193 | 28.145 |
| 01:14 ET | 6861 | 28.17 |
| 01:15 ET | 2444 | 28.16 |
| 01:17 ET | 1756 | 28.16 |
| 01:19 ET | 2227 | 28.155 |
| 01:21 ET | 4340 | 28.13 |
| 01:24 ET | 652 | 28.14 |
| 01:26 ET | 15475 | 28.125 |
| 01:28 ET | 10280 | 28.125 |
| 01:30 ET | 1267 | 28.13 |
| 01:32 ET | 5539 | 28.19 |
| 01:33 ET | 128463 | 28.21 |
| 01:35 ET | 6423 | 28.21 |
| 01:37 ET | 500 | 28.21 |
| 01:39 ET | 3519 | 28.225 |
| 01:42 ET | 1394 | 28.24 |
| 01:44 ET | 5350 | 28.25 |
| 01:46 ET | 3309 | 28.22 |
| 01:48 ET | 6202 | 28.22 |
| 01:50 ET | 5261 | 28.225 |
| 01:51 ET | 1915 | 28.23 |
| 01:53 ET | 1936 | 28.205 |
| 01:55 ET | 7447 | 28.17 |
| 01:57 ET | 3622 | 28.16 |
| 02:00 ET | 2058 | 28.17 |
| 02:02 ET | 5193 | 28.235 |
| 02:04 ET | 5349 | 28.2 |
| 02:06 ET | 2600 | 28.215 |
| 02:08 ET | 4664 | 28.22 |
| 02:09 ET | 1400 | 28.23 |
| 02:11 ET | 2456 | 28.225 |
| 02:13 ET | 6968 | 28.195 |
| 02:15 ET | 3442 | 28.205 |
| 02:18 ET | 3386 | 28.2175 |
| 02:20 ET | 2203 | 28.205 |
| 02:22 ET | 2160 | 28.2 |
| 02:24 ET | 2956 | 28.17 |
| 02:26 ET | 2150 | 28.16 |
| 02:27 ET | 3837 | 28.145 |
| 02:31 ET | 1300 | 28.155 |
| 02:33 ET | 2903 | 28.155 |
| 02:36 ET | 1200 | 28.16 |
| 02:38 ET | 5037 | 28.145 |
| 02:40 ET | 824 | 28.143 |
| 02:42 ET | 2409 | 28.155 |
| 02:44 ET | 15227 | 28.17 |
| 02:45 ET | 1110 | 28.18 |
| 02:47 ET | 2881 | 28.16 |
| 02:49 ET | 1600 | 28.155 |
| 02:51 ET | 9784 | 28.1589 |
| 02:54 ET | 2493 | 28.165 |
| 02:56 ET | 3165 | 28.165 |
| 02:58 ET | 930 | 28.17 |
| 03:00 ET | 4680 | 28.125 |
| 03:02 ET | 3941 | 28.11 |
| 03:03 ET | 1400 | 28.07 |
| 03:05 ET | 1921 | 28.085 |
| 03:07 ET | 1461 | 28.085 |
| 03:09 ET | 3019 | 28.0875 |
| 03:12 ET | 3573 | 28.0502 |
| 03:14 ET | 620 | 28.045 |
| 03:16 ET | 2600 | 28.065 |
| 03:18 ET | 3576 | 28.055 |
| 03:20 ET | 1070 | 28.07 |
| 03:21 ET | 10982 | 28.105 |
| 03:23 ET | 3962 | 28.115 |
| 03:25 ET | 21827 | 28.125 |
| 03:27 ET | 10045 | 28.135 |
| 03:30 ET | 1254 | 28.14 |
| 03:32 ET | 20202 | 28.1 |
| 03:34 ET | 7057 | 28.12 |
| 03:36 ET | 5724 | 28.125 |
| 03:38 ET | 9032 | 28.135 |
| 03:39 ET | 8832 | 28.135 |
| 03:41 ET | 5252 | 28.145 |
| 03:43 ET | 2818 | 28.15 |
| 03:45 ET | 3813 | 28.145 |
| 03:48 ET | 3800 | 28.145 |
| 03:50 ET | 12118 | 28.105 |
| 03:52 ET | 21426 | 28.135 |
| 03:54 ET | 4869 | 28.15 |
| 03:56 ET | 43221 | 28.13 |
| 03:57 ET | 62130 | 28.105 |
| 03:59 ET | 80919 | 28.12 |
Apr 19, 2024
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024, from 8:15AM ET on Friday Apr 19, 2024 by Dow Jones
8:15AM ET on Friday Apr 19, 2024 by Dow Jones
Apr 17, 2024
Royalty Pharma Declares Second Quarter 2024 Dividend, from 8:15AM ET on Wednesday Apr 17, 2024 by Dow Jones
8:15AM ET on Wednesday Apr 17, 2024 by Dow JonesPress Release: Royalty Pharma Declares Second Quarter 2024 Dividend, from 8:15AM ET on Wednesday Apr 17, 2024 by Dow Jones
8:15AM ET on Wednesday Apr 17, 2024 by Dow Jones
Apr 12, 2024
DJ Royalty Pharma Is Maintained at Buy by B of A Securities, from 8:11AM ET on Friday Apr 12, 2024 by Dow Jones
8:11AM ET on Friday Apr 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Royalty Pharma PLC | 16.7B | 11.1x | +1.83% |
Amneal Pharmaceuticals Inc | 1.8B | -19.1x | --- |
Catalent Inc | 10.1B | -7.8x | --- |
Jazz Pharmaceuticals PLC | 6.8B | 18.2x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Prestige Consumer Healthcare Inc | 3.5B | -43.7x | --- |
Company Information
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Contact Information
- Headquarters
- 110 East 59th StreetNEW YORK, NY, United States 10022
- Phone
- 212-883-0200
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Pablo Legorreta
- Vice Chairman, Executive Vice President
- Christopher Hite
- Chief Financial Officer, Executive Vice President
- Terrance Coyne
- Executive Vice President - Investments and Chief Legal Officer
- George Lloyd
- Executive Vice President - Research and Investments
- Marshall Urist
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $16.7B |
|---|---|
Revenue (TTM) | $2.4B |
Shares Outstanding | 597.4M |
Dividend Yield | 2.99% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-14-24 |
Beta | 0.47 |
EPS | $2.54 |
Book Value | $14.61 |
P/E Ratio | 11.1x |
Price/Sales (TTM) | 7.1 |
Price/Cash Flow (TTM) | 9.8x |
Operating Margin | 63.37% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
